Key facts
- This page summarizes Carmen Chang's Form 4 filing for Mirum Pharmaceuticals, Inc. (MIRM).
- 4 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 15 Jun 2023, 16:29.
Carmen Chang - 13 Jun 2023 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- MIRM
- Reported as of
- 13 Jun 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 15 Jun 2023, 16:29:48 UTC
- Prior SEC filing
- 26 May 2023
- Next SEC filing
- 19 Jul 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Louis Citron, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Carmen Chang filed Form 4 for Mirum Pharmaceuticals, Inc. (MIRM) on 15 Jun 2023.
Change
- Previous filing in this sequence was filed on 26 May 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MIRM
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- -2,000,000
- Change %
- -48%
- Price
- $0.000000
- Shares after
- 2,186,243
- Date
- 13 Jun 2023
- Ownership
- See Note 2
- Footnotes
- F1, F2
MIRM
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- +30,000
- Change %
- Price
- $0.000000
- Shares after
- 30,000
- Date
- 13 Jun 2023
- Ownership
- See Note 4
- Footnotes
- F3, F4
MIRM
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- -30,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 13 Jun 2023
- Ownership
- See Note 4
- Footnotes
- F4, F5
MIRM
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- +135
- Change %
- Price
- $0.000000
- Shares after
- 135
- Date
- 13 Jun 2023
- Ownership
- Direct
- Footnotes
- F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Carmen Chang is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 6 footnotes
Footnote F1
New Enterprise Associates 16, L.P. ("NEA 16") made a pro rata distribution of 2,000,000 shares of Common Stock of the Issuer to its general partner and limited partners for no consideration on June 13, 2023.
Footnote F2
The Reporting Person is a manager of NEA 16 GP, LLC ("NEA 16 GP"), which is the sole general partner of NEA Partners 16, L.P. ("NEA Partners 16"). NEA Partners 16 is the sole general partner of NEA 16, the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 16 in which the Reporting Person has no pecuniary interest.
Footnote F3
NEA Partners 16 received 30,000 shares of Common Stock of the Issuer in the distribution made by NEA 16 on June 13, 2023.
Footnote F4
The Reporting Person is a manager of NEA 16 GP, which is the sole general partner of NEA Partners 16, the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA Partners 16 in which the Reporting Person has no pecuniary interest.
Footnote F5
NEA Partners 16 made a pro rata distribution for no consideration of an aggregate of 30,000 shares of Common Stock of the Issuer to its limited partners on June 13, 2023.
Footnote F6
The Reporting Person received 135 shares of Common Stock of the Issuer in the distribution made by NEA Partners 16 on June 13, 2023.